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We developed a transgenic mouse line that expresses the Gi-coupled RASSL (receptor activated solely by synthetic ligand) Ro1 in
astrocytes to study astrocyte–neuronal communication. Surprisingly, we found that all transgenics expressing Ro1 developed hydro-
cephalus. We analyzed these mice in an effort to develop a new model of hydrocephalus that will further our understanding of the
pathophysiology of the disease. Expression of Ro1 was restricted to astrocytes by crossing the transgenic hGFAP-tTA (tet transactivator
behind the human glial fibrillary acidic protein promoter) mouse line with the transgenic tetO-Ro1/tetO-LacZ mouse line. This cross
produced double-transgenic mice that expressed Ro1 in astrocytes. All double transgenics developed hydrocephalus by postnatal day 15,
whereas single-transgenic littermate controls appeared normal. Hydrocephalic Ro1 mice displayed enlarged ventricles, partial denuda-
tion of the ependymal cell layer, altered subcommissural organ morphology, and obliteration of the cerebral aqueduct. Severely hydro-
cephalic mice also had increased levels of phospho-Erk and GFAP expression. Administration of doxycycline to breeding pairs sup-
pressed Ro1 expression and the onset of hydrocephalus in double-transgenic offspring. Ro1 animals maintained on dox did not develop
hydrocephalus; however, if taken off doxycycline at weaning, double-transgenic mice developed enlarged ventricles within 7 weeks,
indicating that Ro1 expression also induces hydrocephalus in adults. This study discovered a new model of hydrocephalus in which the
rate of pathogenesis can be controlled enabling the study of the pathogenesis of both juvenile and adult onset hydrocephalus.
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Introduction
Astrocytes carry out numerous functions critical for the CNS to
develop and operate normally. Certain of these functions are
passive and supportive in nature; for example, astrocytes prevent
neural excitotoxicity by buffering extracelluar potassium (Gab-
riel et al., 1998; Walz, 2000; D’Ambrosio et al., 2002). However,
recent studies suggest astrocytes can actively modulate or initiate
neuronal signaling (Carmignoto et al., 1997; Araque et al., 2000,
2001, 2002; Pasti et al., 2001; Fiacco and McCarthy, 2004). If
astrocytes actively regulate neurophysiology, alterations in astro-
cyte–neuronal signaling could contribute to the etiology of many
CNS disorders. Isolating astrocytic signaling systems to test this
hypothesis is difficult because astrocytes and neurons express a
similar complement of neuroligand receptors (Porter and Mc-
Carthy, 1996). Consequently, neuronal responses to astrocyte
signaling under normal or pathological conditions have been dif-
ficult to measure directly.
We generated a mouse line expressing the Gi-coupled Ro1
receptor activated solely by synthetic ligands (RASSL) in astro-
cytes to directly assess the role of astrocytic G-protein-coupled
receptors (GPCRs) in neurophysiology. Ro1 is a -opioid recep-
tor (KOR) modified by replacing its second extracellular loop
with the second extracellular loop of the -opioid receptor (Fig.
1) and adding the FLAG epitope tag to the N terminus. Conse-
quently, the affinity of Ro1 for endogenous ligands is greatly
reduced while maintaining its ability to bind the synthetic KOR
agonist spiradoline (Coward et al., 1998; Redfern et al., 1999).
Expressing Ro1 in astrocytes on a KOR knock-out background
allows us to activate Gi-coupled receptor signaling in astrocytes
while measuring changes in neuronal excitability.
Restricting Ro1 expression to astrocytes required crossing two
lines of transgenic mice, the Ro1 line and the tet-transactivator
(tTA) line. The Ro1 line carries the Ro1 gene under the control of
the tetO promoter; the tTA line carries the tTA gene under the
control of a 2.0 kb fragment of the human glial fibrillary acidic
protein (hGFAP) promoter. Because Ro1 expression requires
tTA and tTA expression is restricted to GFAP-positive cells,
double-transgenic progeny will express Ro1 only in astrocytes.
Additionally, Ro1 expression levels can be regulated using doxy-
cycline (dox) to bind tTA, preventing it from binding the tetO
promoter. Although double-transgenic mice were obtained in
normal numbers, they unexpectedly developed severe hydro-
cephalus when maintained off dox. This is the first indication that
activating a Gi-coupled GPCR in astrocytes can lead to
hydrocephalus.
Hydrocephalus, the net accumulation of CSF in the ventricu-
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lar system, is a serious neurological disorder whose pathogenesis
is poorly understood. Current treatments carry high risk for ad-
ditional complications (Blount et al., 1993; Bondurant and Jime-
nez, 1995; Patwardhan and Nanda, 2005) and neurological prob-
lems often persist after treatment (Fernell et al., 1994; Mancao et
al., 1998; Del Bigio, 2004). Understanding the causes of hydro-
cephalus is critical for developing new treatment and prevention
options. Our finding suggests aberrant astrocytic signaling may
underlie the development of certain forms of hydrocephalus and
provides a new model in which the timing and progression of
hydrocephalus can be manipulated.
Materials and Methods
Animals. All experiments were performed in accordance with the Insti-
tutional Animal Care and Use Committee at the University of North
Carolina at Chapel Hill and federal guidelines. Animals were maintained
in climate-controlled housing with a 12 h light/dark cycle and were given
food and water ad libitum. The day of birth was defined as postnatal day
0 (P0).
Transgenic mouse lines. The hGFAP-tTA mouse line was made by iso-
lating the tTA gene from pUHD 15-1, kindly provided by H. Bujard
(Universität Heidelberg, Heidelberg, Germany), and cloning it down-
stream of the 2 kb human GFAP promoter in place of lacZ in the
pGFA2lac1 vector (Pascual et al., 2005). The GFAP-tTA-mP1 cassette
was placed between four copies of genomic insulators from chicken
-globin gene (Chung et al., 1993). Transgenic mice were obtained by
standard methods and backcrossed to C57BL/6J for at least five genera-
tions. FVB/N-TgN(tetO-Ro1-LacZ)CONK mice were obtained from
The Jackson Laboratory (Bar Harbor, ME) and crossed to GFAP-tTA
mice to get double-transgenic mice. KOR knock-out mice (Hough et al.,
2000) were obtained courtesy of Dr. John E. Pintar (University of Med-
icine and Dentistry New Jersey, Piscataway, NJ).
Doxycycline administration. Selected animals were given 25 g/ml dox
(Sigma, St. Louis, MO) in the drinking water. Amber bottles were used to
protect the dox from light and the water was changed once a week.
Breeding pairs on dox were given dox water at the time of mating and
maintained on dox continuously. Breeding pairs off dox were never ex-
posed to dox.
Immunofluorescence. Adult (P45–P60; n  13) mice were deeply anes-
thetized and transcardially perfused with cold 4% paraformaldehyde/
0.1 M NaPO4, pH 7.4. Brains were removed and postfixed overnight at
4°C in the same buffer. To detect the Ro1 receptor, sections were probed
for FLAG, the peptide (DYKDDDDK) epitope tag fused to the N termi-
nus of Ro1. For FLAG staining, 50 m sections were cut on a vibratome,
washed in alternating PBS and PBS/0.5% Triton X-100 (Tx-100) washes,
and blocked in PBS/0.5% Tx-100/10% NGS/0.2% gelatin/3% milk. Sec-
tions were incubated with primary antibodies (rabbit anti-FLAG; Sigma)
diluted in PBS/0.5% Tx-100/3% NGS/0.2% gelatin overnight at 4°C with
gentle agitation. Sections were extensively washed in PBS and PBS/0.2%
Tx-100. Secondary antibodies (goat anti-rabbit IgG conjugated to Alexa-
488; Invitrogen, Carlsbad, CA) were diluted in PBS/0.5% Tx-100/5%
NGS/0.2% gelatin and applied for 2– 4 h at room temperature. For GFAP
and NeuN staining, fixed brains were cryoprotected in PBS/30% sucrose
overnight at 4°C. Sections (14 m) were cut on a cryostat, blocked for
2– 4 h in PBS/20% normal goat serum/2% BSA/0.2% Tx-100 at room
temperature, and incubated overnight with primary antibodies (mouse
anti-GFAP; 1:500; Sigma; mouse anti-NeuN; 1:1000; Chemicon, Te-
mecula, CA) diluted in the same buffer. After washing, sections were
incubated with secondary antibodies (goat anti-mouse conjugated to
Alexa-488 and goat anti-rabbit conjugated to Alexa-594; Invitrogen) di-
luted 1:400 in blocking buffer for 2– 4 h at room temperature.
Xgal histochemistry. Adult mice (P30 –P45; n  6) were deeply anes-
thetized and transcardially perfused with cold 4% paraformaldehyde/
0.1 M NaPO4, pH 7.4. One hundred micrometer sections were cut on a
vibratome. Sections were washed three times (10 min each) at room
temperature in Xgal rinse buffer (0.1 M KPO4, pH 7.4, 2 mM MgCl2,
0.01% sodium deoxycholate, 0.2% Igepal CA-630) and stained overnight
at 37°C in Xgal stain buffer [rinse buffer plus 1 mg/ml 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside, 5 mM K3Fe(CN)6, and 5 mM
K4Fe(CN)6].
Immunoprecipitation/Western blotting. Fresh brain tissue (P21–P50;
n  15) was homogenized in ice-cold lysis buffer (50 mM Tris-HCl, pH
7.4, 100 mM NaCl, 5 mM EDTA, 50 mM NaF, 10 mM NaPP, 200 M
Na3VO4, 1% Tx-100, 100 g/ml PMSF, 1 g/ml leupeptin, 2 g/ml
aprotinin, 1 g/ml soybean trypsin inhibitor, 1 g/ml pepstatin A, 10
g/ml benzamidine) and sonicated on ice. Lysates were incubated on a
rotator for 1 h at 4°C. Supernatants were precleared and incubated for 2 h
at 4°C with M2 FLAG antibody (Sigma) and protein A/Sepharose beads
(Sigma) that had been blocked with BSA. Beads were boiled in Laemmli
buffer, run on an SDS-PAGE gel, and blotted onto a nitrocellulose mem-
brane. The blots were blocked in 5% milk–TBS/0.1% Tween 20 (TBST)
for 2 h at room temperature and probed overnight at 4°C with a 1:250
dilution of a rabbit anti-FLAG polyclonal antibody (Sigma) in 5% milk/
TBST. Membranes were washed in TBST, probed with HRP-conjugated
goat anti-rabbit IgG (1:10,000), and processed for ECL. For GFAP, fresh
brains (P21–P35; n  6) were dissected in ice-cold PBS, and tissues were
homogenized in a volume of homogenization buffer (50 mM HEPES, pH
7.3, 150 mM NaCl2, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Tx-100
with Complete protease inhibitor (Roche Diagnostics, Mannheim, Ger-
many) equal to 10 tissue weight. The samples were sonicated and cen-
trifuged. Equal amounts of protein were run on a Tris-glycine gel, blotted
onto a nitrocellulose membrane, and probed with rabbit anti-GFAP an-
tibody (DakoCytomation; 1:5000) for 48 h at 4°C.
Hematoxylin and eosin staining. Brains from perfused animals (P30 –
P66; n  14) were drop-fixed in 10% formalin overnight, rinsed in dis-
tilled water, and stored in 70% ethanol. The fixed brains were taken to the
University of North Carolina histology core for paraffin embedding and
staining with hematoxylin and eosin. Sections (6 m) were cut on a
sliding microtome.
Immunocytochemistry. Brains from adult mice (P30 –P45; n  11)
were fixed in 4% paraformaldehyde, cryoprotected in PBS/30% sucrose,
and cut in 35 m sections on a cryostat. Sections were rehydrated in PBS
and incubated in 100% methanol at 20°C for 10 min. Sections were
washed three times (10 min each) in TBST and once in TBS before
incubating for 2 h in blocking buffer (5.5% NGS/5.5% BSA/TBST) at
room temperature. Avidin/biotin was blocked using an avidin/biotin
blocking kit (Vector Laboratories, Burlingame, CA) according to the
manufacturer’s protocol. Primary antibodies [rabbit anti-phospho-
p44/42 mitogen-activated protein (MAP) kinase (Thr202/Tyr204); Cell
Signaling Technology, Beverly, MA; 1:250; or mouse anti-GFAP; Sigma;
Figure 1. Ro1 structure [from Coward et al. (1998)]. To create Ro1, the second extracellular
loop of the -opioid receptor was replaced with the second extracellular loop of the -opioid
receptor. A FLAG tag was added to the N terminus for detection. Ro1 has a greatly reduced
affinity for endogenous ligands but still responds to the small molecule drug spiradoline.
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1:500] were diluted in blocking buffer, and sections were incubated over-
night at 4°C. Biotinylated goat anti-rabbit secondary antibody (Vec-
tastain Elite ABC kit; Vector Laboratories) was diluted 1:500 in TBS/3%
BSA, and sections were incubated for 2 h at room temperature. Sections
were then incubated for exactly 30 min in 0.6% H2O2 at room tempera-
ture. ABC reagent was prepared according to kit instructions, and sec-
tions were incubated for 2 h at room temperature. DAB reagent (Vector
Laboratories) was added, and the reaction was allowed to proceed until
sufficient staining developed. Coverslips were mounted using Vectashield
with DAPI (4,6-diamidino-2-phenylindole) (Vector Laboratories).
Ventricle size. Brains fixed in 4% paraformaldehyde were embedded in
agarose and cut coronally into 500 m (P15; n  22) or 375 m (P0; n 
24) sections on a vibratome (Leica VT 1000S; Leica, Nussloch, Ger-
many). Sequential sections were viewed under a light microscope (Zeiss,
Oberkochen, Germany), and images were collected using MetaMorph
imaging software. The section at the level of striatum and anterior com-
missure was selected from each animal, and the size (maximum width) of
the lateral ventricles was measured using the MetaMorph software and
divided by the maximum brain width. The resulting ratio of ventricle to
brain diameter provides a measurement of hydrocephalus severity (Jones
et al., 2001a). Hydrocephalic phenotypes were classified as mild (0.20 –
0.40), moderate (0.41– 0.60), or severe (0.60).
Results
Expression of Ro1
Mice expressing Ro1 in astrocytes were generated by crossing the
hGFAP-tTA mouse line to the tetO-Ro1/tetO-LacZ mouse line.
This genotype was moved onto a KOR knock-out background
(Hough et al., 2000) to prevent spiradoline from activating en-
dogenous -opioid receptors. KOR//hGFAP-tTA/ or
KOR//hGFAP-tTA/ mice were crossed to KOR//tetO-
Ro1/tetO-LacZ/ mice to produce double-transgenic (hGFAP-
tTA//tetO-Ro1/tetO-LacZ/) and control (hGFAP-tTA/,
tetO-Ro1/tetO-LacZ/, or neither) littermates, all on the KOR
background. Double-transgenic mice (hereafter referred to as
Ro1 mice) were produced in expected numbers. To determine
that Ro1 expression was restricted to astrocytes, brain sections
from Ro1 mice were probed with anti-FLAG (the epitope tag
fused to Ro1) plus anti-GFAP (glial fibrillary astrocytic protein,
an astrocytic marker) or anti-NeuN (neuronal nuclei, a neuron-
specific nuclear protein) antibodies. Positive FLAG staining was
apparent in most brain regions, including cortex, hippocampus,
cerebellum, and thalamus. FLAG staining was observed in GFAP-
positive cells but not in NeuN-positive cells (Fig. 2A,B), confirm-
ing that Ro1 expression is astrocytic.
Because Ro1 expression is driven by the tetO system, dox can
be used to manipulate when Ro1 is expressed. To verify that dox
represses Ro1 expression, brain tissue extracts from Ro1 animals
(P60) that had been maintained off dox, Ro1 animals that had
been maintained on 25 g/ml dox, and C57BL/6J wild-type con-
trol animals were immunoprecipitated with a monoclonal Flag
antibody. A band at 44 kDa, consistent with the predicted size
of the receptor, along with bands representing multimers of the
receptor were detected in extracts from animals maintained off
Figure 2. Ro1 expression is restricted to astrocytes and is regulated by dox. A, B, Hippocam-
pal brain sections were double-stained for FLAG and GFAP (astrocyte marker) or FLAG and NeuN
(neuronal marker). A, Positive FLAG staining (left, arrow) colocalized with GFAP (right, arrow)
but not with NeuN (B). The arrows point to the same cell. Scale bars, 100 m. C, Brain lysates
from a C57BL/6 control mouse, Ro1 mouse on dox (25 g/ml), and Ro1 mouse off dox were
immunoprecipitated with FLAG monoclonal antibody, and the blots were probed with FLAG
polyclonal antibody. Only the Ro1 mouse off dox had positive bands (solid arrows). A nonspecific
band was found in all samples (arrowhead). Br, Brain; Hipp, hippocampus; Ce, cerebellum.
Figure 3. LacZ expression is regulated by dox. Brain sections from Ro1 mice on dox (25
g/ml) (B, D, F ) and Ro1 mice off dox (A, C, E) were stained by Xgal histochemistry. Ro1
animals on dox had no detectable positive cells, whereas robust staining was seen in Ro1
animals off dox, indicating that dox is effectively controlling expression. Scale bars: A, B, 150
m; C–F, 50 m.
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dox. No FLAG-specific bands were de-
tected in wild-type mice or Ro1 mice on 25
g/ml dox, indicating that 25 g/ml dox
represses Ro1 expression (Fig. 2C). Be-
cause Ro1 mice also carry a tetO-LacZ
transgene, we used Xgal histochemistry to
confirm that dox regulates expression
(Fig. 3). No Xgal staining was detected in
any brain region of sections from Ro1
mice on 25 g/ml dox. Strong Xgal stain-
ing was observed in the hippocampus,
thalamus, and brainstem of mice main-
tained off dox; weak Xgal staining was seen
in the cortex.
Ro1 mice develop hydrocephalus
Although Ro1 mice off dox appear grossly
normal at birth, by P15, 100% of Ro1 mice off dox begin to
exhibit macrocephalus characterized by a swollen, dome-shaped
cranium (Fig. 4B). By 12 weeks of age, all Ro1 mice off dox
develop severe hydrocephalus and 50% die (Fig. 4C). Survival
studies were terminated at 12 weeks because of the severe mor-
bidity of the remaining Ro1 animals. Dissection of the brain re-
vealed greatly enlarged ventricles filled with fluid, indicative of
hydrocephalus and impaired CSF homeostasis. Blood on the sur-
face of the brain was frequently observed in hydrocephalic mice,
and on occasion excess CSF was seen between the skull and brain
surface. Control littermates (hGFAP-tTA/ only or tetO-Ro1/
tetO-lacZ/ only) and Ro1 mice on 25 g/ml dox appear nor-
mal at P15 and do not develop macrocephalus at any age, indi-
cating that the insertion of either or both genes does not cause
hydrocephalus.
To further characterize the progression of hydrocephalus in
Ro1 mice, the ventricle size of litters off dox were examined at P0
and P15 (Fig. 5). At P0, Ro1 mice (n  10) and control littermates
(n  14) showed no enlargement of the lateral ventricles. At P15,
however, all Ro1 mice (n  12) exhibited enlarged ventricles with
a ventricle-to-brain ratio 0.30, whereas control littermates (n 
10) had an average ratio of 0.10. We observed variation in the
severity of the hydrocephalus phenotype (Table 1) as defined in
Materials and Methods. The severity of hydrocephalus is not
linked to homozygosity because all animals measured were het-
erozygous for both transgenes. The severity of hydrocephalus
continued to progress with age because all Ro1 animals off dox
developed severe hydrocephalus by P30 (Fig. 5G) (E. J. Sweger,
unpublished observations).
Brains of four control mice (single transgenic, P30 –P125) and
five hydrocephalic Ro1 (P30 –P68) mice off dox were serially sec-
tioned and stained with hematoxylin and eosin for a more de-
tailed histological analysis (Fig. 6). The most striking feature of
the hydrocephalic brains was the greatly enlarged lateral ventri-
cles (Fig. 5G). The third ventricle, optic recess, pineal recess, and
intraventricular foramen were also enlarged. The cerebral cortex
was reduced in thickness, with the most severely affected animals
exhibiting an almost completely atrophied cortex. All cortical
layers appeared to be present (data not shown). The septum and
retrosplenial cortex– hippocampus transition were disrupted;
other brain regions, including the hippocampus, appeared com-
pressed and caudally displaced. Red blood cells indicative of re-
cent hemorrhaging were found throughout the brain (data not
shown). The white tract tissue underlying the lateral ventricles
was disrupted, and there was an incomplete denudation of
ependymal cells lining the lateral (data not shown) and third
ventricles (Fig. 6 J). In some instances, the ependymal layer ap-
pears to be separated from the underlying tissue (Fig. 6F). Al-
though it is possible that the separation is attributable to a fixa-
tion artifact, ependymal layer separation was not observed in
Figure 5. Ro1 mice develop progressive enlargement of the lateral ventricles. At birth, whole brains and coronal sections of Ro1 mice (b, B) and single-transgenic control littermates (a, A) are
indistinguishable. By P15, brains from Ro1 mice (d, e, D, E) are larger than controls (c, C) and have pronounced enlargement of the lateral ventricles. The hydrocephalus in Ro1 mice can be classified
as mild (D) (n  4), moderate (E) (n  6), or severe (data not shown) (n  2) cases based on ventricle-to-brain ratio. By P30, Ro1 mice (G) have severe hydrocephalus characterized by greatly
enlarged lateral ventricles and extremely thin cortex. Control mice at P30 (F ) appear normal. All mice were maintained off dox.
Figure 4. Ro1 mice maintained off dox develop hydrocephalus. B, C, All Ro1 pups from breeding pairs maintained off dox (B)
develop overt hydrocephalus, and 50% die by 12 weeks of age (C). A, Ro1 mice maintained on dox (25 g/ml) appear normal.
Mice shown are P45.
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control mice. Where intact, the ependymal cell layer appeared
thinner (Fig. 6B,D,F), and not all ependymal cells were ciliated.
The rostral end of the aqueduct of Sylvius was completely oblit-
erated (Fig. 6H), suggesting that hydrocephalus results in part
from the blocked flow of CSF between the third and fourth ven-
tricles. No ependymal cells were detected at the site of obstruction
and the surrounding tissues appeared vacuolated. Abnormalities
in the subcommissural organ (SCO) have been implicated in
other models of hydrocephalus (Jones and Bucknall, 1988; Perez-
Figares et al., 2001; Bach et al., 2003; Blackshear et al., 2003;
Fernandez-Llebrez et al., 2004; Jones et al., 2004; Krebs et al.,
2004); likewise, in Ro1 brains, the SCO appeared disorganized
(Fig. 6D).
To determine whether Ro1 must be expressed early in devel-
opment in order for hydrocephalus to develop, mice were kept on
25 g/ml dox until weaning (P21) and maintained off dox until
P60. Because of hardening of the skull, none of the mice taken off
dox developed overt enlargement of the cranium by P60; how-
ever, Ro1 mice (n  4) had enlarged lateral ventricles with an
average ventricle-to-brain ratio of 0.30. In comparison, the
ventricle-to-brain ratio for littermate controls (n  2) was 0.11,
similar to that of Ro1 mice (n  8; ratio, 0.15) and controls (n 
7; ratio, 0.13) that were maintained on dox continuously until
P60 (Fig. 7). Hydrocephalus appears to develop with Ro1 expres-
sion independent of age and thus is not dependent on processes
linked to early stages of development.
GFAP expression in Ro1 mice
Increased GFAP expression, an indicator of reactive glia, is ob-
served in most forms of damage to the brain, including hydro-
cephalus. Increased levels of GFAP staining were seen in hydro-
cephalic Ro1 mice. The hippocampus and cortex, a region
typically low in GFAP immunoreactivity (Fig. 8C), showed the
greatest increases in GFAP staining compared with control mice
(Fig. 8B). Western blots confirmed that GFAP protein levels were
elevated in the cortex and hippocampus of Ro1 mice; GFAP levels
in cerebellar tissue extracts from the same mice appeared similar
to controls (Fig. 8A).
Phospho-Erk is elevated in Ro1 mice
Because Gi-coupled receptors are known to activate the MAP
kinase pathway, coronal sections from Ro1 mice were stained for
phosphorylated extracellular signal-regulated kinase (Erk) p44/
42, the active form of Erk p44/42. Increased phospho-Erk stain-
ing was observed in the superficial layers of entorhinal cortex and
in the striatum surrounding the lateral ventricles of Ro1 animals
off dox, but not in littermate single-transgenic controls (Fig. 9).
Discussion
To investigate how Gi protein signaling in astrocytes affects brain
neurophysiology, we expressed the RASSL Ro1, a Gi-coupled
GPCR, in astrocytes using the hGFAP promoter and the tet-off
system. Unexpectedly, all mice expressing Ro1 developed non-
communicating triventricular hydrocephalus. Hydrocephalus
appears to result from Ro1 expression, because single-transgenic
mice do not develop hydrocephalus as would be expected if
caused by an insertional defect. Moreover, when Ro1 expression
is repressed with dox, hydrocephalus is also inhibited. Ro1 mice
taken off dox at weaning (P21) develop enlarged ventricles, fur-
ther supporting the idea that hydrocephalus is a consequence of
Ro1 expression.
At birth, Ro1 mice off dox appeared grossly normal and were
Table 1. Severity of hydrocephalic phenotype in P15 Ro1 mice




Figure 6. Alterations in the ventricular system of hydrocephalic Ro1 mice. Hematoxylin and
eosin staining of coronal sections from single-transgenic control (P45, left column) and Ro1
(P33, right column) mice. A, B, In Ro1 mice (B), the third ventricle at the level of the periven-
tricular hypothalamic nucleus is reduced in size and the ependymal cell layer appears thinner
compared with controls (A). D, F, H, J, The subcommissural organ is disorganized in Ro1 mice
(D), and there is a partial denudation of ependymal cells lining the ventricular walls (F, arrow-
head; J ). The remaining ependymal cells have fewer cilia (F, arrow), and the aqueduct is oblit-
erated with no apparent ependymal cell layer (H ). C, E, G, I, In control mice, the subcommissural
organ (C) and aqueduct (G) show normal morphology. The ependymal layer is intact with
multiple cilia per cell (E, arrow; I ). E and F are enlargements of the boxes in C and D, respec-
tively. Mice were maintained off dox. Aq, Aqueduct; SCO, subcommissural organ; III, third ven-
tricle; PC, posterior commissure. Scale bars: A, B, G, H, I, J, 50 m; C, D, 100 m; E, F, 30 m.
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indistinguishable from their control litter-
mates, but began to exhibit macrocephaly
between P10 and P15. At P15, Ro1 mice
have a lateral ventricle-to-brain ratio that
exceeds 0.30 and by P30 have developed a
severe hydrocephalus phenotype charac-
terized by greatly dilated lateral and third
ventricles that caudally displace sur-
rounding brain structures. The rostral end
of the Sylvius aqueduct is obliterated, with
no lumen and no detectable ependymal
cells visible in coronal sections of this re-
gion, suggesting a denudation of epen-
dymal cells has occurred. The collicular
recess and caudal end of the Sylvius aque-
duct, however, remain open. The SCO
also appears disorganized in hydroce-
phalic mice, although it is unclear whether
this is attributable to Ro1 expression or
whether it is a result of hydrocephalus.
It is unclear how, in the absence of ap-
plied ligand, Ro1 expression leads to the
development of hydrocephalus. Ro1 is
likely to be highly overexpressed relative
to other astrocytic receptors. Because
G-protein-coupled receptors have a low
level of constitutive activity (Costa and
Cotecchia, 2005), Ro1 may be expressed at
a high enough level that its constitutive
activity is sufficient to trigger a series of
events that ultimately result in hydroceph-
alus. Ro1 may be also expressed at a high
enough level that dynorphin or another
ligand that normally would have a low af-
finity for Ro1 can bind and activate the
receptor. Significantly, mice with Ro1 ex-
pression targeted to the heart developed
cardiomyopathology when taken off dox.
When these mice were given an interme-
diate dose of dox to reduce Ro1 expres-
sion, their heart rates normalized. Treat-
ing these mice with pertussis toxin or the
KOR antagonist nor-binaltorphimine also
restored normal heart rates, demonstrat-
ing that Ro1 signaling was responsible for
the changes in heart physiology (Redfern
et al., 2000). A similar process in which
Ro1 overexpression and constitutive ac-
tivity leads to pathology may be occurring
in our mice.
Our finding is, to our knowledge, the
first to implicate astrocytic Gi signaling
pathways in the development of hydro-
cephalus. Ro1 expression in astrocytes
may contribute to the development of hy-
drocephalus by altering the extracellular
matrix so that more fluid from the extra-
cellular space enters the ventricles. It could also alter the levels of
various neurotransmitters, growth factors, or cytokines in the
CSF, resulting in a dysregulation of CSF production by the cho-
roid plexus. Astrocytic release of glutamine is known to be down-
regulated in the kaolin model of hydrocephalus (Kondziella et al.,
2003); it is possible that increased Gi signaling in astrocytes may
affect glutamine production or release that in turn changes neu-
ronal input into the SCO. It is interesting to note that gene ex-
pression analysis in the H-Tx rat, which has primary stenosis of
the aqueduct similar to Ro1 mice, has implicated several genes
linked to astrocytes and G-protein-coupled receptors, including
connexin 30, -integrin 5, and somatostatin (Jones et al., 2001b;
Miller et al., 2006).
Figure 7. Ro1 mice will develop enlarged ventricles if taken off dox at weaning. A, B, In litters taken off dox at weaning (P21),
Ro1 mice (B) develop enlarged ventricles when compared with single-transgenic littermate controls (A). C, D, Ro1 mice (D) have
normal ventricles when mice were kept on dox continuously compared with single-transgenic littermate controls (C). All mice
were processed at P60. A, n  2; B, n  4; C, n  7; D, n  8.
Figure 8. GFAP expression is upregulated in hydrocephalic Ro1 mice. Brain lysates from two Ro1 mice with severe hydroceph-
alus and one littermate control (P22) were separated by SDS-PAGE and probed with anti-GFAP antibody (A). Ro1 mice have
increased GFAP levels in the hippocampus and cortex. Brain sections from control (B) and Ro1 (C) mice were stained for GFAP to
show increased expression. Cortical sections are shown; pial surface is on the top right corner. Scale bar, 50 m.
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Although SCO secretory function could not be determined
from our histological examination of Ro1 brains, the observation
that the SCO is disorganized in Ro1 mice is significant. The pres-
ence of a normal SCO appears to be necessary for the develop-
ment and maintenance of the aqueduct, because impaired SCO
formation and/or function are found in multiple animal hydro-
cephalus models and in human infantile hydrocephalus (Over-
holser et al., 1954; Newberne, 1962; Takeuchi and Takeuchi,
1986; Jones et al., 1987; Jones and Bucknall, 1988; Takahashi et
al., 1997; Perez-Figares et al., 1998; Takahashi et al., 1998; Louvi
and Wassef, 2000; Estivill-Torrus et al., 2001; Sakakibara et al.,
2002; Fernandez-Llebrez et al., 2004). The SCO secretes nega-
tively charged glycoproteins, such as SCO-spondin and RF-Gly I,
that appear to be critical for maintaining an open aqueduct by
their physical presence. The SCO may also regulate CSF forma-
tion. Receptors for SCO glycoproteins are found on the choroid
plexus (Miranda et al., 2001), suggesting that CSF production
could be influenced by SCO activity. It would be interesting to
determine whether any of these parameters are altered in Ro1
mice.
We have shown that phospho-Erk lev-
els are increased in hydrocephalic mice.
Gi-coupled receptors are known to signal
via the MAP kinase pathway; thus, Ro1
signaling may lead to changes in gene ex-
pression that contribute to the pathogen-
esis of hydrocephalus. We cannot rule out,
however, the possibility that phospho-Erk
is increased in response to hydrocephalus.
Elevated phospho-Erk has been associated
with astrogliosis (Mandell and Vanden-
Berg, 1999), a pathological response of as-
trocytes to many types of brain injury, in-
cluding hydrocephalus (Fukumizu et al.,
1996). Increased GFAP expression ob-
served in severely hydrocephalic Ro1 mice
is indicative of astrogliosis, particularly
because GFAP levels are not elevated in
Ro1 mice with mild hydrocephalus (data
not shown).
The observed loss of ependymal cells in
Ro1 mice is in agreement with other stud-
ies that demonstrate a denudation of
ependymal cells in the ventricular system
(Jimenez et al., 2001; Dominguez-Pinos et
al., 2005). In these models, denudation be-
gins embryonically and precedes the clo-
sure of the aqueduct and subsequent ven-
tricle enlargement (Wagner et al., 2003).
The underlying cause of ependymal de-
tachment is unknown, although defects in
certain adhesion molecules, such as L1,
have been indicated (Schmid et al., 2000;
Itoh et al., 2004). Because a subset of
ependymal cells express GFAP (Takano et
al., 1996; Rodriguez-Perez et al., 2003), it
is possible that Ro1 may be expressed in
these cells, causing a defect that leads to
detachment. Ependymal cells may also be
affected indirectly by changes in levels of
secreted cytokines or altered neuronal in-
puts resulting from Ro1-induced changes
in astrocyte signaling.
New treatments for hydrocephalous are clearly needed. Hy-
drocephalus occurs at a rate of 0.48 –3 in 1000 births (Mangano et
al., 1998; Fletcher and Northrup, 2000; Ding et al., 2001; Del
Bigio, 2004) and is the most common neurological disorder re-
quiring surgery among children (Casey et al., 1997). Mortality
rates as high as 96% are reported for children that are left un-
treated (Laurence and Coates, 1962; Yashon et al., 1965; Eckstein
and Macnab, 1966). Shunting off the excess CSF, thereby reliev-
ing intracranial pressure and preventing additional tissue dam-
age, is the most effective treatment to date. Yet shunting is not
ideal because it does not address underlying causes of hydroceph-
alus and the procedure itself carries significant health risks.
Shunting does not restore normal CSF circulation, which is im-
portant for carrying growth factors and cytokines to neuronal
and glial precursor cells in the germinal matrix surrounding the
lateral ventricles (Miyan et al., 1998). Children treated with
shunts frequently have residual neurological deficits (Fernell et
al., 1990, 1994; Fletcher et al., 1992; McAllister et al., 1998), in-
cluding impaired memory (Scott et al., 1998). Shunts are also
associated with a high risk for complications such as infection,
Figure 9. Phospho-Erk p44/42 levels are elevated in hydrocephalic Ro1 mice. Increased phospho-Erk p44/42 staining is ob-
served around the lateral ventricles (B) and in the entorhinal cortex (D) of hydrocephalic Ro1 mice but not in littermate single-
transgenic controls (P21) (A, C). No increases in phospho-Erk were observed in the hippocampus (F ). Sections shown in A and B are
at the level of the anterior commissure and striatum; C–F are at the level of the subcommissural organ. Scale bars, 150 m. LV,
Lateral ventricle; DG, dentate gyrus.
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obstruction, and over drainage (Pople et al., 1990; Blount et al.,
1993); nearly 70% of shunts require revision within 10 years.
To develop more effective treatments, a better understanding
of hydrocephalus pathogenesis is needed. The Ro1 model of hy-
drocephalus has several characteristics that will make it valuable
for studying hydrocephalus. First, the Ro1 model does not re-
quire injection of foreign bodies into the ventricles to cause hy-
drocephalus, making the Ro1 model easier to work with and
more relevant to human cases. Second, hydrocephalic animals
are produced reliably; all Ro1 mice will develop hydrocephalus if
maintained off dox. Inherited models of hydrocephalus, such as
the H-Tx rat, reliably produce hydrocephalic offspring but at a
much lower rate, and which animals will develop hydrocephalus
cannot be predicted at early ages (Jones et al., 2000, 2001b; Miller
et al., 2006). Third, dox can be used to regulate when hydroceph-
alus will occur. It would be interesting to compare juvenile and
adult onset to see whether age changes how hydrocephalus devel-
ops. Fourth, the rate of development and the severity of hydro-
cephalus can be manipulated by giving Ro1 mice a lower concen-
tration of dox. Slowing the development of hydrocephalus allows
changes in the brain to be studied more thoroughly and could
provide insights into how hydrocephalus progresses. The Ro1
model of hydrocephalus should prove useful in advancing our
knowledge of hydrocephalus pathophysiology. Furthermore, the
Ro1 model provides new evidence for the involvement of astro-
cytic G-protein-coupled receptor signaling in the development of
hydrocephalus.
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